A clone encoding a human D2 dopamine receptor was isolated from a pituitary cDNA library and sequenced. The deduced protein sequence is 96% identical with that of the cloned rat receptor with one major difference: the human receptor contains an additional 29 amino acids in its putative third cytoplasmic loop. Southern blotting demonstrated the presence of only one human D2 receptor gene. Two overlapping phage containing the gene were isolated and characterized. DNA sequence analysis of these clones showed that the coding sequence is interrupted by six introns and that the additional amino acids present in the human pituitary receptor are encoded by a single exon of 87 base pairs. The involvement of this sequence in alternative splicing and its biological significance are discussed. Dopamine neurons in the vertebrate central nervous system are involved in the initiation and execution of movement, the maintenance -of emotional stability, and the regulation of pituitary function. Several human neurological diseases, including Parkinson disease (1) and schizophrenia (2) , are thought to be manifestations of imbalances between dopamine receptors and dopamine. The receptors that mediate dopamine's effects have been divided into D1 and D2 subtypes, which are distinguished by their guanine nucleotidebinding protein (G-protein) coupling (3, 4), ligand specificities, anatomical distribution, and physiological effects (5). The D2 dopamine receptors have been of particular clinical interest due to their regulation of prolactin secretion (6) and their affinity for antipsychotic drugs (7, 8).
Dopamine neurons in the vertebrate central nervous system are involved in the initiation and execution of movement, the maintenance -of emotional stability, and the regulation of pituitary function. Several human neurological diseases, including Parkinson disease (1) and schizophrenia (2) , are thought to be manifestations of imbalances between dopamine receptors and dopamine. The receptors that mediate dopamine's effects have been divided into D1 and D2 subtypes, which are distinguished by their guanine nucleotidebinding protein (G-protein) coupling (3, 4) , ligand specificities, anatomical distribution, and physiological effects (5) . The D2 dopamine receptors have been of particular clinical interest due to their regulation of prolactin secretion (6) and their affinity for antipsychotic drugs (7, 8) .
The D2 dopamine receptors belong to the family of Gprotein-coupled receptors. The sequence similarity shared by members of this family enabled Bunzow et al. (9) to clone a rat brain D2 dopamine receptor cDNA. We have used that clone to isolate the human pituitary D2 dopamine receptor cDNA described here. § We have found that the deduced amino acid sequences of these two receptors are very similar, with one notable difference. The human receptor contains an additional 29 amino acids in its putative third cytoplasmic loop that are encoded by one of the gene's exons. This genomic organization suggests that the existence of two D2 receptor mRNAs is the result of an alternative splicing event.
MATERIALS AND METHODS Cloning of the Human Pituitary cDNA. Human pituitary tissue was a generous gift from N. Seidah and M. Chretien (Clinical Research Institute of Montreal). Poly(A)+ mRNA and cDNA were prepared as described (9) . The cDNA was size-selected [1-6 kilobases (kb)] in agarose gels, isolated using Geneclean (Bio 101, La Jolla, CA), ligated to EcoRI adaptors, cloned into AgtlO arms (Stratagene), and packaged (Gigapack Gold, Stratagene). Recombinants (1.5 x 106) were screened on replica nylon filters (DuPont Colony/Plaque Screen hybridization filters) with 32P-labeled hybridization probes. Prehybridization and hybridization were performed in 50% formamide/1% SDS/2x SSC (lx SSC is 0.15 M NaCl/0.015 M sodium citrate, pH 7) at 370C. The complete sequences of both strands of DNA were determined in M13mpl9 by using Sequenase (United States Biochemical) primed with synthetic oligonucleotides.
Expression and Pharmacology. The 2.5-kb human pituitary cDNA (hPitD2) was cloned into pZem3 (a gift from E. Mulvihill, Zymogenetics, Seattle) and cotransfected with pRSVneo into thymidine kinase-deficient mouse cells (Ltkcells) by calcium phosphate precipitation (10) . A stable transfectant (L-hPitD2Zem) was selected and maintained in medium containing G418 sulfate (Geneticin; GIBCO) at 750 ,ug/ml. Twenty hours prior to the harvesting of membranes, these cells were incubated with 70 ,uM zinc sulfate. Membranes were prepared from L-HPitD2Zem, from the Ltk-cell line expressing the cloned rat D2 dopamine receptor (LRGB2Zem-1), and from freshly dissected rat striata (Taconic Farm, Germantown, NY) as described (11, 12) . For the binding assays, membrane protein was used at 10-15 ,g from L-hPitD2Zem, 50-75 ,ug from L-RGB2Zem-1, and 200-250 ,tg from rat striatum. The binding assays were incubated at 37°C for 60 min in 50 mM Tris HCl/120 mM NaCI/5 mM KCl/2 mM CaCI2/1 mM MgCI2, pH 7.4, and then stopped by rapid filtration over glass-fiber filters (no. 32; Schleicher & Schuell) that had been presoaked in 0.5% polyethyleneimine.
The filters were washed twice in ice-cold 50 mM Tris HCl, pH 7.4. Saturation curves were generated using increasing concentrations of the highly D2-specific antagonist [3H]domperidone (13) . Antagonist drugs were evaluated for their ability to inhibit specific binding of [3H]domperidone (1 nM) . The Bmax, Kd, and IC50 values were determined as described (14) .
Southern Blotting. Human genomic DNA prepared from a normal male donor was a gift from M. Litt. Three micrograms of DNA was digested with restriction enzymes and the fragments were electrophoresed in 0.7% agarose and blotted onto nitrocellulose filters (Schleicher & Schuell). Prehybridization and hybridization were performed at 37°C in 50% formamide as described (15 probe, three partial cDNAs were isolated from a human pituitary library and sequenced; Two oligonucleotide probes based on these sequences were used to isolate a fourth cDNA, hPitD2, which encoded a full-length receptor protein (Fig. 1) . The human pituitary receptor contains seven putative transmembrane domains and lacks a signal sequence. Overall the human and rat nucleotide sequences are 90% identical and show 96% identity at the amino acid level. Several consensus sequences for N-linked glycosylation, protein kinase A phosphorylation, and palmitoylation (18) are conserved between the human and rat receptors. There are also 18 amino acid differences (including one deletion) between these proteins and, strikingly, the human pituitary receptor contains an additional 29 amino acids in its putative third cytoplasmic loop.
Expression and Pharmacological Evaluation of hPitD2 cDNA. To evaluate the pharmacological characteristics of the human pituitary receptor, its cDNA was subcloned into pZem3 and expressed in mouse Ltk-cells (L-hPitD2Zem).
Membranes prepared from these cells showed specific binding of [3H]domperidone, a D2-selective antagonist (12, 13) , with a Bmax of 4.05 ± 0.3 pmol per mg of protein (n = 2) and a Kd of 0.74 ± 0.11 nM (n = 2). This Kd value is in excellent agreement with the published value of0.74 nM in mouse brain membranes (13 membranes was inhibited by a number of D2-specific drugs (Fig. 2) . Their rank order of potency was spiperone > (+)-butaclamol > haloperidol > sulpiride. The selective serotonin antagonist mianserin and the Dl-selective antagonist SCH 23390 inhibited domperidone binding only at very high concentrations, as did the inactive isomer (-)-butaclamol. These values are essentially identical to those obtained with membranes from Ltk-cells transfected with the cloned rat D2 dopamine receptor cDNA (L-RGB2Zem-1) and from rat striatum ( Table 1) . Human D2 Dopamine Receptor Gene. By using portions of the rat cDNA as probe, a clone was isolated from a human genomic library. This genomic clone, AHD2G1, contained a 1.6-kb BamHI fragment that encoded the last 64 amino acids of the human D2 receptor and 1.2 kb of 3' noncoding sequence. The 1.6-kb fragment was used to probe a Southern blot of human genomic DNA digested with three restriction enzymes. Each enzyme generated a single fragment that hybridized to the probe (Fig. 3) indicating that there is probably only one human D2 dopamine receptor gene.
To-isolate a-genomic clone that encoded the N terminus of the human receptor protein, a 118-base-pair (bp) restriction fragment from the cloned rat D2 receptor cDNA (corresponding to amino acid residues 1-39) was used to screen a second genomic library. AHD2G2 was isolated and found to overlap with AHD2G1 by 400 nucleotides (Fig. 4a) . Together, these phage span 34 kb of the human D2 dopamine receptor gene locus, DRD2 (19) , and contain the sequence found in the hPitD2 cDNA plus sequences that extend 15 kb downstream of the polyadenylylation signal and 3.7 kb upstream of the translation initiation site. To characterize the intron/exon structure of the gene, a genomic sequencing approach employing oligonucleotide probes and chemical cleavage was used (Fig. 4b) . Since the divergence of nucleotide sequences between human and rat members of this receptor family is ==10% (unpublished observations), we were able to initiate the genomic sequencing by relying on hybridization probes and restriction sites that are present in the cloned rat D2 receptor cDNA. Our results demonstrate that the coding portion of the human D2 receptor gene is divided into seven exons (Fig. 4b) . Interestingly, we found that exon 5 is 87 bp long and encodes the entire 29-amino acid sequence present in the cloned human pituitary receptor (Figs. 1 and 4c) . Analysis of the six introns revealed that each contains acceptor and donor sequences that conform to the GT/AG rule (20) , as summarized in Fig. 5 . The approximate sizes of the introns were based on the results of Southern blotting experiments (data not shown). When compared, the genomic and cDNA sequences were found to differ by only two silent transitions, one at 939 (T to C in the gene) and the other at 957 (C to T in the gene). Fig. 1 ). ilar to that of the human cDNA and establishes that D2 receptors containing the 29 residues are not unique to the human pituitary.
The human D2 receptor expressed in L-hpitD2Zem cells has essentially the same drug binding profile as do rat striatum and L-RGB2Zem-1 membranes. Therefore, since the 29 amino acids do not affect binding they may be involved in other levels of receptor function. For example, the third cytoplasmic loop of the 032-adrenergic receptor has been shown to be required for appropriate G-protein coupling (21) . Therefore, one possibility is that this sequence may influence whether D2 receptor stimulation inhibits adenylate cyclase, activates potassium channel conductance, or inhibits calcium mobilization (22) . Another possibility is that the 29 amino acids differentiate postsynaptic D2 receptors from presynaptic autoreceptors (23) . Since a computer search (VAX/IntelliGenetics; September 1989) failed to identify another sequence of significant homology, we consider this sequence to be unique to the D2 receptor.
Based on the comparison of genomic and cDNA sequences, the human D2 dopamine receptor gene is divided into at least seven exons. It is possible that one or more additional exons remain to be identified at the 5' end of the gene as was shown to be the case with muscarinic receptor genes (24) .
The interruption ofcoding sequence by introns distinguishes the human D2 receptor gene from most other members of the G-protein-coupled receptor gene family with the exception of the opsin genes (25) . One significant observation is that the placement of two introns (numbers 3 and 5) in this human gene corresponds almost precisely to intron positions conserved in bovine and Drosophila opsin genes (26, 27 protein structure (29) . That introns are found following transmembrane segments II, III, and IV (see Figs. 1 and 4) argues that the repeated structural motifs characteristic of these receptors may have evolved by internal duplication. Furthermore, the presence of several introns within the third cytoplasmic loop provides an explanation of the substantial variation in length observed across the family (30) . The possibility of alternatively spliced D2 dopamine receptor mRNAs giving rise to structurally distinct forms of receptor is exciting. The expression of one form of the D2 receptor mRNA or another represents a level of control that may have implications with respect to human disease.
